Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study is a six-week, randomized, placebo-controlled, fixed dose trial comparing cannabidiol Vs. placebo added to a stable dose of antipsychotic medications in patients diagnosed with schizophrenia.
Epistemonikos ID: 70f8bcdf5bc7102c8e08069907095e8e8b4e849c
First added on: May 04, 2024